Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Development of nanoparticles incorporated with quercetin and ACE2-membrane as a novel therapy for COVID-19

Abstract Introduction Angiotensin-converting enzyme 2 (ACE2) and AXL tyrosine kinase receptor are known to be involved in the SARS-CoV-2 entry of the host cell. Therefore, targeting ACE2 and AXL should be an effective strategy to inhibit virus entry into cells. However, developing agents that can si...

Full description

Bibliographic Details
Main Authors: Jia-You Fang, Kuo-Yen Huang, Tong-Hong Wang, Zih-Chan Lin, Chin-Chuan Chen, Sui-Yuan Chang, En-Li Chen, Tai-Ling Chao, Shuenn-Chen Yang, Pan-Chyr Yang, Chi-Yuan Chen
Format: Article
Language:English
Published: BMC 2024-04-01
Series:Journal of Nanobiotechnology
Subjects:
Nanoparticles
Quercetin
AXL
ACE2
COVID-19
Online Access:https://doi.org/10.1186/s12951-024-02435-2

Internet

https://doi.org/10.1186/s12951-024-02435-2

Similar Items